Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study

Table 3

Results of the poststudy patient questionnaire.

Question	Responses (Requip/Ralnea/Similar)	Chi-square test
Overall which formulation had better efficacy?	9/4/8	0.368
Which formulation had better control on motor symptoms?	10/3/8	0.156
Which formulation had better control on nighttime symptoms?	5/6/10	0.368
Which formulation had better control on nonmotor symptoms?	8/0/13	0.275
Which formulation would you like to receive after the completion of the study?	12/9	0.513